Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.08.27.672736

Sister chromatid separation determines the proliferative characteristics upon whole-genome duplication through homologous chromosome rearrangement

Abstract

Whole-genome duplication (WGD) of diploid cells triggers various cell fates, such as cell death, cell cycle arrest, and proliferation with chromosome instability, contributing to broad bioprocesses, including differentiation, tumorigenesis, or aging. However, factors determining the post-WGD cell fates remain largely unknown. In this study, we found that cytokinesis failure (CF) and mitotic slippage (MS), two major routes of WGD induction, differentially affected post-WGD viability and proliferation in human cells. Quantitative live imaging revealed poorer survivability of cells upon multipolar chromosome segregation at the first mitosis after MS than CF. Chromosome-specific labeling showed that the inefficient sister chromatid separation upon MS caused more skewed homologous chromosome distribution than CF. The skewed homologue distribution frequently led to physical isolation (> 10 m) of the centrosomes from all homologous centromeres, hindering these centrosomes from capturing any of these homologues. The difference in the frequency of this nullisomic chromosome segregation between MS and CF at least partially explained their difference in the viability of the subsequent daughter cells. Moreover, artificial separation of sister chromatids upon MS improved the evenness of homologue distribution, suppressed nullisomic homologue segregation in the following mitosis, and significantly restored the viability of their daughter cells. These results demonstrate the geometric arrangement of homologous chromosomes, defined by the presence or absence of sufficient sister chromatid separation upon WGD, as a key factor determining the proliferative characteristics of subsequent progenies. Our findings would provide a clue to understanding the route-dependent outcomes of WGD in cell fate determination in different bioprocesses. SignificanceWhole-genome duplication (WGD), doubling of cellular content through skipping cell division after DNA synthesis, drives cellular diversification in development, aging, tumorigenesis, or evolution. While various mechanisms of WGD are featured in different biological contexts, the potential impacts of differences in WGD mechanisms on resulting cellular properties have been overlooked. Here, we discovered that two major mechanisms of WGD, mitotic slippage and cytokinesis failure, differentially affect proliferative characteristics of post-WGD cells through their contrasting intracellular reorganizations. Mitotic slippage, occurring with inefficient sister chromatid separation, led to a skewed homologous chromosome distribution compared to cytokinesis failure, fueling lethal chromosome loss by non-random chromosome segregation immediately after WGD. Our findings provide insights into the context-dependent preferences for WGD mechanisms.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Inoko, M., Yang, G., Tsukada, Y., Uehara, R.. 2025-08-30. Sister chromatid separation determines the proliferative characteristics upon whole-genome duplication through homologous chromosome rearrangement. https://doi.org/10.1101/2025.08.27.672736

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

Tracking the conformational dynamics of single molecules in live cells; GTPase cycling in Cdc42 gradients and microclusters

The Rho family of GTPases play a critical role in many cellular processes by acting as molecular switches relying on conformational changes to transition between active and inactive states. The spatial distribution and kinetics of these conformational changes are complex and vary across the cell. We describe here biosensors based on environment-responsive fluorescent dyes, capable of reporting the conformational changes of individual GTPase molecules as they traffic within living cells (SPARC Cdc42 and SPARC Rac1, 'Single Particle Activation Reporter Constructs'). We use SPARC Cdc42 to determine the rates of different steps in GTPase regulation, activation/inactivation and membrane insertion, that together generate localized gradients of Cdc42 activity driving cell motility. The biosensors also revealed heterogeneously distributed clusters of Cdc42, the mechanisms of their activation, and potential roles in polarized motility.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗